Oh, J., Yi, S., Gu, N., Shin, D., Yu, K., Yoon, S. H., . . . Jang, I. (2018). Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity. Genomics Inform.
Citação norma ChicagoOh, Jaeseong, Sojeong Yi, Namyi Gu, Dongseong Shin, Kyung-Sang Yu, Seo Hyun Yoon, Joo-Youn Cho, and In-Jin Jang. "Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity." Genomics Inform 2018.
MLA CitationOh, Jaeseong, et al. "Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity." Genomics Inform 2018.